Table 2. Pathological features of patients enrolled in the study.
Patient # | Tumor histology | Grading | TNM |
---|---|---|---|
1 | Bladder carcinoma | 2 | 1a |
2 | Bladder carcinoma | 3 | 1 |
3 | Bladder carcinoma | 3 | 3a |
4 | Bladder carcinoma | 3 | Tis |
5 | Bladder carcinoma | 3 | 3 |
6 | Bladder carcinoma | 2 | 2 |
7 | Bladder carcinoma | 3 | Tis |
8 | Bladder carcinoma | 3 | 2 |
9 | Bladder carcinoma | 3 | 2 |
10 | Bladder carcinoma | 3 | 3 |
11 | Bladder carcinoma | 3 | 3b |
12 | Bladder carcinoma | 3 | Tis |
13 | Bladder carcinoma | 3 | 1 |
14 | Bladder carcinoma | 3 | 3a |
15 | Bladder carcinoma | 3 | 3b |
16 | Bladder carcinoma | 3 | 3b |
17 | Bladder carcinoma | 2 | Ta |
18 | Bladder carcinoma | 3 | 3 |
19 | Bladder carcinoma | 3 | 3b |
20 | Bladder carcinoma | 3 | 4b |
21 | Bladder carcinoma | 3 | 3b |
22 | Bladder carcinoma | 3 | 2 |
23 | Bladder carcinoma | 3 | 4a |
24 | Bladder carcinoma | 3 | 3b |
25 | Bladder carcinoma | 2 | Tis |
26 | Bladder carcinoma | 2 | Tis |
27 | Bladder carcinoma | 3 | 3a |
28 | Bladder carcinoma | 3 | 3b |
29 | Renal cell carcinoma | 3 | 3a |
30 | Renal cell carcinoma | 2 | 3a |
31 | Renal cell carcinoma | 3 | 2 |
32 | Renal cell carcinoma | 4 | 2 |
33 | Renal cell carcinoma | 4 | 3a |
34 | Renal cell carcinoma | 3 | 1 |
35 | Renal cell carcinoma | 4 | 3a |
36 | Renal cell carcinoma | 3 | 1 |
37 | Renal cell carcinoma | 3 | 1 |
38 | Renal cell carcinoma | 2 | 2b |
39 | Renal cell carcinoma | 3 | 3 |
40 | Renal cell carcinoma | 3 | 1a |
41 | Renal cell carcinoma | 2 | 2 |
42 | Renal cell carcinoma | 3 | 3a |
43 | Renal cell carcinoma | 2 | 3 |
44 | Renal cell carcinoma | 2 | 2 |
45 | Renal cell carcinoma | 4 | 3a |
46 | Renal cell carcinoma | 2 | 1b |
47 | Renal cell carcinoma | 3 | 3b |
48 | Renal cell carcinoma | 2 | 1b |